Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
10/2008
10/28/2008CA2152979C Poly-perfluoroalkyl-substituted alcohols and acids, and derivatives thereof
10/23/2008WO2008128056A1 Bisphosphonate compounds and methods with enhanced potency for multiple targets including fpps, ggpps, and dpps
10/23/2008WO2008127935A1 Metal complex compositions and methods for making metal-containing films
10/23/2008WO2008125911A2 Hydrogen splitting composition
10/23/2008WO2008125788A1 Cyanine derivatives, fluorescent conjugates containing same and use thereof
10/23/2008WO2008125483A2 Multi step synthesis of ibandronate
10/23/2008WO2008101881A3 Alkyl h-phosphonates of n,n'-dialkylimidazoliums and of quaternary ammoniums, and uses thereof
10/23/2008WO2008011559A3 Synthetic lung surfactant and use thereof
10/23/2008US20080262269 Metal complex containing ligand; catalyst for hydrogenation, hydroformylation, oxidation, epoxidation, Diels-alder reaction
10/23/2008US20080261923 Inhibitory activity against Pin1; inhibit peptidyl-prolyl isomerase activity of Pin1; inhibits growth of cancer cells; Ac-Phe-Tyr-phosphoSer- pseudo amide -Pro-Arg-NH2; Fmoc-bis(POM) phosphoSer- pseudo amide -Pro-2-aminoethyl-(3-indole) and their Phospho-(D)-serine stereoisomers
10/23/2008US20080261913 Compounds and pharmaceutical compositions for the treatment of liver disorders
10/23/2008US20080261865 Oxidized Lipids and Uses Thereof in the Treatment of Inflammatory Diseases and Disorders
10/23/2008US20080261237 Inositol-Phosphate Derivatives and Method of Detecting Inositol-1-Phosphate
10/23/2008US20080260685 Prodrugs of cc-1065 analogs
10/23/2008US20080258113 Trihexyl(tetradecyl) phosphonium chloride; anionic halide, phosphinate, sulphonate, amide, tosylate, aluminate, borate; anhydrous solvent; Grignard reagent, hydridic BH3, NaBH4, metal, amalgam; tetrahydrofuran, benzene, toluene co-solvent; products isolated in liquid phase layer separate from solvent
10/23/2008DE102007018456A1 Aryl- und/oder Heteroaryl-substituierte Hauptgruppenelementhalogenide und/oder -pseudohalogenide, Verwendung von Hauptgruppenelementhalogeniden und/oder -pseudohalogeniden, organisches halbleitendes Matrixmaterial, elektronische und optoelektronische Bauelemente Aryl and / or heteroaryl substituted Hauptgruppenelementhalogenide and / or pseudohalides, using main group element and / or pseudohalides, organic semiconducting matrix material, electronic and optoelectronic devices
10/23/2008DE10164041B4 Verfahren zur Herstellung von Vitamin-A-Estern A process for producing vitamin A esters
10/23/2008CA2683971A1 Multi step systhesis of ibandronate
10/23/2008CA2682694A1 Bisphosphonate compounds and methods with enhanced potency for multiple targets including fpps, ggpps, and dpps
10/23/2008CA2670972A1 Controlled gas release from a melt processable compatible polymer blend
10/23/2008CA2669545A1 Frustrated lewis pair compositions
10/22/2008EP1982989A1 Bis(phosphine)boronium salts, process for preparation of bis(phosphine)boronium salts, and bis(phosphine)boronium salts prepared by the process
10/22/2008EP1981896A2 An improved process for the preparation of risedronate sodium hemi-pentahydrate
10/22/2008EP1981837A2 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
10/22/2008EP1408984B1 Organo-phosphorous compounds for activating gamma/delta t cells
10/22/2008EP0958298B2 Blocked mercaptosilane coupling agents for filled rubbers
10/22/2008EP0846098B2 Improved metal-ligand complex catalyzed processes
10/22/2008CN101291943A Novel coupler and application thereof
10/22/2008CN101291942A Diaryl alkylphosphonates and methods for preparing same
10/22/2008CN101289465A Process for preparing di(phosphoric acid pentaerythrite ester)phosphoric acid melamine salts
10/22/2008CN101289464A Process for recovering triphenyl phosphine oxide and 2-mercaptobenzothiazole from production waste liquid of cephalothin active ester
10/22/2008CN101289463A Competitive hapten of ethyl alkron, competitive antigen and uses thereof
10/22/2008CN101289462A Process for preparing acephate from ethenone
10/22/2008CN101289461A Process for extracting phytic acid from virus-free waste liquid of rapeseed extraction
10/22/2008CN101289455A Anti-influenza virus precursor drug and uses thereof
10/22/2008CN101289438A 3-(3í»-hydroxyl)-butyl phthalide ester, and preparation thereof and uses
10/22/2008CN100427495C Phosphite derivative, its preparing process, and catalyst precarsor containing phosphite
10/22/2008CN100427494C Prepn of fire retardant resorcinol tetraphenyldiphosphate
10/22/2008CN100427493C Ligands for pnicogen chelate complexes with a metal of subgroup viii and use of the complexes as catalysts for hydroformylation, carbonylation, hydrocyanation or hydrogenation
10/22/2008CN100427454C Method for producing difluoro-acetyl-acetic acid alkylesters
10/22/2008CN100427139C Water-soluble shps as novel alkylating agents
10/21/2008US7439401 Process for preparing acylphosphanes and derivatives thereof
10/21/2008US7439385 Reacting carboxylic acid with phosphorus acid and halophosphorus compound selected from phosphorus tri- and pentachloride, phosphorus tri-and pentabromide, and phosphorus oxychloride and oxybromide in presence of diphenyl ether; treatment of bone disorders, osteoporosis, Paget's disease
10/21/2008US7439350 Chemical intermediates for viricides, antitumor agents, anticarcinogenic agents
10/21/2008US7439341 Monitoring polymerase chain reactions
10/21/2008US7439314 Catalysts for olefin polymerization
10/21/2008US7439249 such as 2-(7-acetylamino-1-furano-2-ylmethyl-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-succinic acid; for treatment of autoimmune diseases, proliferative diseases, angiogenic disorders, and/or cancers; catheters, prosthetics
10/21/2008US7438818 Cross-linked polyimine and use thereof for the immobilization of acidic or electrophilic compounds present in a solution
10/21/2008CA2478768C Purification of onium hydroxides by electrodialysis
10/16/2008WO2008124097A2 Salts of isophosphoramide mustard and analogs thereof
10/16/2008WO2008122957A1 Deposition of ta- or nb-doped high-k films
10/16/2008WO2008122620A1 Iso ca-4 and analogues thereof as potent cytotoxic agents inhibiting tubuline polymerisation
10/16/2008WO2008044245A3 A process for the preparation of risedronate sodium hemipentahydrate
10/16/2008WO2008013659A3 Single precursors for atomic layer deposition
10/16/2008WO2007130783A3 Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates
10/16/2008US20080255391 Stereoselective preparation of P-chiral four-co-ordinated phosphorus compound (o-Tolylphenylmethylphosphine oxide) by reacting chiral alcohol, chiral amine or chiral thiol, with P-chiral three-co-ordinated phosphorus compound, in presence of electrophile
10/16/2008US20080255386 Process for preparing ibandronate
10/16/2008US20080255381 Bisbiphenylacylphosphine oxide and preparation method therefore
10/16/2008US20080255366 prepared by dissolving zoledronic acid in solvents comprising water, heating and cooling the solution to crystallize zoledronic acid trihydrate
10/16/2008US20080255356 5,5'-bis(disubstitutedphosphino)-1,1',3,3'-tetraalkyl-4,4'-bipyrimidine-2,2',6,6'-(1H,1'H,3H,3'H)-tetrone used as as ligands to generate chiral transition metal catalysts, for asymmetric allylic substitution reactions
10/16/2008US20080255355 Chiral Diphosphonites as Ligands in the Ruthenium-Catalyzed Enantioselective Reduction of Ketones, B-Ketoesters and Ketimines
10/16/2008US20080255287 Formed by reacting a bis(fluorophenyl)phosphine oxide with an excess of an aromatic diol in the presence of an alkali metal carbonate and reacting the oligomer product with a phthalonitrile (nitrophthalonitrile); the phthalonitrile formed is reacted with a curing agent to form a thermosetting resin
10/16/2008US20080255182 Certain chemical entities, compositions, and methods
10/16/2008US20080255070 Bisphosphonate Compounds and Methods with Enhanced Potency for Multiple Targets including FPPS, GGPPS, AND DPPS
10/16/2008US20080255056 Salts of isophosphoramide mustard and analogs thereof
10/16/2008US20080254970 Ammonium(bisaquo oxobisoxalato)niobate and hydrates; high purity catalyst and/or ceramic dopant materials; tailor made batch formulations with optional additives
10/16/2008US20080254695 Liquid Textile-Pretreating Agent
10/16/2008US20080254546 Arsenic complexes; transmetallization
10/16/2008US20080254216 complex capable of being used for chemical vapor deposition of thin metal , or metal oxide films
10/16/2008US20080253982 Ascorbic acid derivatives and skin-whitening cosmetics
10/16/2008US20080251759 Metathesis of a a quaternary ammonium, phosphonium or sulfonium cation forming a salt of hydrogencarbonate, carbonate, monoalkylcarbonate or monoarylcarbonate; storage stablility
10/16/2008US20080251754 Ionic onium compound with imidide; high ionic conductivity, delocalized anionic charge
10/16/2008US20080251169 Ionic liquid, a method of synthesizing an ionic liquid, a precursor of an explosive composition including at least one ionic liquid, and a method of desensitizing an explosive composition
10/16/2008DE102008010534A1 Neuartige Phosphonium-Basierte ionische Flüssigkeit sowie diese verwendendes Reaktionslösungsmittel Novel phosphonium-based ionic liquid-use and this reaction solvent
10/16/2008DE102007017657A1 Tris/heterocyclyl)-Metallkomplexe als Bleichkatalysatoren Tris / heterocyclyl) metal complexes as bleach catalysts
10/16/2008CA2684747A1 Salts of isophosphoramide mustard and analogs thereof
10/15/2008EP1980565A1 Oil soluble radiation curable metal-containing compounds and compositions
10/15/2008EP1979368A2 Compounds and methods for the treatment of cancer
10/15/2008EP1979367A2 Quinolin-4-one derivatives as modulators of abc transporters
10/15/2008EP1979366A2 N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use
10/15/2008EP1979365A2 Functionalised nanoparticles, their production and use
10/15/2008EP1979361A2 Oxonium and sulfonium salts
10/15/2008EP1742642B1 Phosphonate analogs of hiv integrase inhibitor compounds
10/15/2008EP1585750B1 Narcistatin prodrugs
10/15/2008EP0363415B1 Compounds for the treatment of alzheimer's disease
10/15/2008CN101284848A Synthetic method of clinic effect of alendronate
10/15/2008CN101284847A Production method of N-phosphono methyliminodiacetic acid
10/15/2008CN101284846A Reactive phosphoric acid esters wedding agents and method for preparing same
10/15/2008CN101284791A Electrolytic solution for storage device, and electric double layer capacitor
10/15/2008CN101284790A 离子液体 Ionic Liquids
10/15/2008CN100425614C Amino trimethylene phosphonic acid with content of greater than or equal to 90 percent and process for making same
10/14/2008US7435847 Preparation of solid ammonium glyphosate using organic solvent in extraction
10/14/2008US7435841 Preparation of halohydrocarbyl phosphonic acid diesters
10/14/2008US7435840 Method for producing orthometalated and orthosubstituted metallocenes
10/14/2008US7435827 Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
10/14/2008US7435746 4-{2-[(R)-2-((E)-3-Hydroxy-4-phenyl-but-1-enyl)-6-oxo-piperidin-1-yl]-ethylsulfanyl}-butyric acid or the methyl ester; glaucoma, intraocular hypotensive agents
10/14/2008US7435739 Antiproliferative agents; skin, prostate glands, kidneys, central nervous system
10/14/2008CA2419279C Prodrugs to nmda receptor ligands
10/14/2008CA2333888C Production of optically active phospholanes
10/09/2008WO2008122030A2 Carbon dioxide scrubbing using ionic materials